How 2′-Fucosyllactose (2′-FL) May Help Reverse Non-Alcoholic Steatohepatitis (NASH) by Remodelling the Gut Microbiome
Nonalcoholic steatohepatitis (NASH) is a progressive liver disease with limited treatment options and a growing global burden. Emerging research suggests the gut microbiome plays a critical role in disease development...






